Blog

  1. April 18, 2024

    Podcast: Clearing the air on compounding GLP1 drugs

    The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

    It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

    It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

    Check out "Compounded GLP1s" on the Game Changers podcast — click here or check your favorite podcast app.

    Read More
  2. April 17, 2024

    Revelation's Emily Durham talks technician career options

    Check it out: The latest edition of the CPhT Connect podcast features Revelation Pharma's own VP of business development, Emily Durham, MS, CPhT.

    That VP title might clue you into the fact that Emily isn't working as a pharmacy technician right now. Hence her episode, "Exploring Career Path Options" that's all about how she took a leap of faith to leave the pharmacy counter for "a fulfilling career that blends her passion for sales with her love for compounding."

    Explore the challenges and rewards of charting new territories in pharmacy, as Emily discusses the thrill of creating innovative solutions and overcoming obstacles in her role. Hear firsthand about the power of belief in oneself and the importance of confidence in achieving personal and professional growth.

    Check out CPhT Connect wherever you get your

    Read More
  3. April 15, 2024

    Revelation Pharma Appoints Brad Leach as Senior Vice President of 503B

    Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.

    With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.

    Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.

    Prior to joining Revelation Pharma,

    Read More
  4. April 15, 2024

    Revelation Pharma included in prestigious Pharmacy500 list

    Revelation Pharma included in prestigious Pharmacy500 list

    We're throwing a little party here at Revelation Pharma HQ: We've just been named to the 2024 Pharmacy500 list from RxInsider.

    What's that list, you ask? The official description: "The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year".

    The emphasis is ours because we're incredibly proud of that — of being able to make such a big difference in the compounding pharmacy space in such a short amount of time. The Revelation Pharma vision of innovation and knowledge-sharing covers the country from coast to coast, and it's only getting bigger.

    Our staff is made up of exceptional, dedicated, relentless people, and we're thrilled to see them recognized. (Psst: Did you

    Read More
Page